| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |